TipRanks
Go Ultimate55% OFF

Chewy (3HH) AI Stock Analysis

DE:3HH

Chewy

(XETRA:3HH)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Recurring Autoship RevenueAutoship’s high contribution to sales and faster growth than the overall business create a recurring revenue base with stronger customer retention and purchase frequency. This supports demand visibility, improves engagement, and gives Chewy a durable foundation for scaling fulfillment and health offerings.
Negative Factors
Persistent Consumer and Discretionary PressureA pressured consumer environment can restrain demand for discretionary pet items, premium products, and add-on purchases, limiting customer-spend expansion. If household formation and cost pressures remain weak, Chewy may need to rely more heavily on core consumables and execution to sustain growth.

Chewy (3HH) vs. iShares MSCI Germany ETF (EWG)

-50%-40%-30%-20%-10%0%10%20%DE:3HH-32.52%EWG+4.43%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
EUR 8.56B
Dividend Yield
―
Average Volume (3M)
304
Price to Earnings (P/E)
32.3
Beta (1Y)
0.47
Revenue Growth
-0.63%
EPS Growth
72.15%
Country
Germany
Employees
18,000
Sector
Consumer Cyclical
Sector Strength
61
Industry
Specialty Retail

Chewy Business Overview & Revenue Model

Company Description

Chewy, Inc., along with its affiliated entities, functions exclusively as an online retail enterprise within the United States. Through its primary website, chewy.com, and its mobile applications, the company provides a comprehensive range of product...

Chewy Earnings Call Summary

Earnings Call Date:Sep 08, 2026(Q2-2026)|% Change Since:-5.61%|Next Earnings Date:Dec 02, 2026
Earnings Call SentimentPositive

The call was strongly positive overall. Chewy reported 7.3% revenue growth, continued market-share gains, active-customer and Autoship growth, substantial year-over-year margin expansion, strong momentum in health and acquired businesses, early AI benefits, and improved full-year guidance. These positives outweighed the pressured consumer environment, discretionary and premiumization weakness, limited pricing contribution, timing-related nature of much of the Q2 margin upside, and expected fuel and seasonal headwinds.

Positive Updates

Strong Q2 Revenue and Market-Share Performance
Q2 total enterprise net sales reached $3.33 billion, at the high end of guidance, representing 7.3% year-over-year growth. Organic net sales excluding SmartPak and Modern Animal increased 5.7%, driven by active customer growth, NEST Pack expansion, and ongoing market-share gains. Chewy continued to outperform the broader pet category by roughly 2x to 3x.

Negative Updates

Pet Market Remains Under Consumer Pressure
Chewy did not see a meaningful recovery in the pressured consumer backdrop for the pet market and is not assuming a meaningful consumer recovery for the balance of fiscal 2026. Management said the environment has stabilized rather than deteriorated further, but the outlook assumes no improvement in consumer behavior.

Company Guidance

For fiscal year 2026, Chewy expects total net sales of $13.46 billion to $13.57 billion, representing year-over-year growth 6.8% to 7.7%, including organic net sales growth of 5.5% to 6.3%, with the midpoint not assuming any meaningful improvement in the consumer environment; adjusted EBITDA margin guidance is 6.7% to 6.8%, from 6.6 to 6.8%, implying over 100-base-points of year over year adjusted EBITDA margin expansion and $912 million of adjusted EBITDA at the midpoint. For the third quarter, net sales are expected at $3.323 billion to $3.358 billion, representing reported year over year growth of 6.6% to 7.7% and organic net sales growth of 5.3% to 6.2%, adjusted EBITDA margins of 6.6% to 6.7%, roughly 85-basis-points of year over year expansion at the midpoint, and adjusted diluted earnings per share of around $0.39; full-year guidance also includes share based compensation expense, including related tax taxes, broadly flat to last year, weighted average diluted shares outstanding of approximately 410 million shares, net interest expense of $10 million to $15 million, capital expenditures of 1.5% to 2% of net sales, an effective tax rate of 24% to 26%, full year gross margin expansion at a more moderate pace than fiscal 2025, a mid single digit million dollar fuel headwind, and full year free cash flow through of roughly 80%. AI related initiatives are expected to generate low-tens of millions of dollars of cost savings in fiscal 2026, scaling to approximately $50 million on an annualized basis in fiscal 2027.

Chewy Risk Analysis

Chewy disclosed 51 risk factors in its most recent earnings report. Chewy reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

0 New Risks

Chewy Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

DE:3HH against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
AMZNAMZN74Outperform$2.59T19.1726.71%―15.35%73.92%
Sector *61Neutral$18.38B12.79-2.54%3.03%1.52%-15.83%
TSCOTSCO60Neutral$17.68B18.2537.64%2.80%3.53%-10.44%
WOOFWOOF59Neutral$747.56M23.582.58%―-1.32%―
BARKBARK43Neutral$72.27M-2.22-39.54%―-21.25%-5.40%
PETSPETS43Neutral$25.80M-0.86-91.67%―-19.67%34.91%

* Consumer Cyclical Sector Average

Performance Comparison

-50%-25%0%25%50%DE:3HHAMZNPETSTSCOBARKWOOFDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
DE:3HH and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:3HHChewy Inc18.77-9.84-34.39%
AMZNAmazon.Com, Inc.240.35-13.65-5.37%
PETSPetmed Express1.19-1.25-51.23%
TSCOTractor Supply Company33.94-17.32-33.78%
BARKBARK Inc Class A8.00-9.00-52.94%
WOOFPetco Health And Wellness Company Inc2.61-0.57-17.92%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.